Relmada, which has turned to strategic options after scrapping two phase 3 trials in major depressive disorder (MDD), is ...

Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from ...

Relmada Therapeutics has acquired complete worldwide ownership rights to Sepranolone from Sweden-based Asarina Pharma.

Low-quality information on social media may be contributing to a rise in teen mental illness. A new construct may help ...

Pennsylvania Governor Josh Shapiro proposed legalizing recreational marijuana during his budget address on Tuesday. The ...

TEL AVIV, Israel, Feb. 04, 2025 (GLOBE NEWSWIRE) -- . (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage ...

However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...

After revealing she was in remission from MS in 2021, the actor is sharing a glimpse into life with the condition.

In a series on people with special needs in Pittsburgh's workforce, this story looks at the anxiety and importance of disability evaluations.

MacDonald wonders what format a reality TV show might take to best capture the lives of people with hemophilia.

There's a big stigma surrounding Tourette syndrome and other brain disorders, but Milan teacher Larry Biederman is working to break that by showing his students how they can be successful despite ...